Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart J Pocock

Showing results (301-310 of 349) with videos related to

Pageof 35
Sort By:
Lancet (London, England)|December 25, 2017
Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trialPhilip M Bath, Lisa J Woodhouse, Jason P Appleton, et al.
Circulation. Cardiovascular Interventions|June 6, 2018
Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients)Usman Baber, Shawn X Li, Rebecca Pinnelas, et al.
Journal of the American College of Cardiology|November 4, 2016
2-Year Outcomes of High Bleeding Risk Patients After Polymer-Free Drug-Coated StentsPhilippe Garot, Marie-Claude Morice, Damras Tresukosol, et al.
The New England Journal of Medicine|November 25, 2006
Bivalirudin for patients with acute coronary syndromesGregg W Stone, Brent T McLaurin, David A Cox, et al.
Annals of Internal Medicine|January 29, 2019
External Validation of the MEESSI Acute Heart Failure Risk Score: A Cohort StudyDesiree Wussler, Nikola Kozhuharov, Zaid Sabti, et al.
Circulation|September 13, 2022
Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection FractionJaved Butler, Gerasimos Filippatos, Tariq Jamal Siddiqi, et al.
The New England Journal of Medicine|October 27, 2025
Transcatheter or Surgical Aortic-Valve Replacement in Low-Risk Patients at 7 YearsMartin B Leon, Michael J Mack, Philippe Pibarot, et al.
Lancet (London, England)|September 2, 2025
β blockers after myocardial infarction with mildly reduced ejection fraction: an individual patient data meta-analysis of randomised controlled trialsXavier Rossello, Eva Irene Bossano Prescott, Anna Meta Dyrvig Kristensen, et al.
JAMA|February 15, 2007
Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trialGregg W Stone, Michel E Bertrand, Jeffrey W Moses, et al.
Lancet (London, England)|March 24, 2009
Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trialsMark A Hlatky, Derek B Boothroyd, Dena M Bravata, et al.
Pageof 35

Showing results (301-310 of 349) with videos related to

Sort By:
Pageof 35
Lancet (London, England)|December 25, 2017
Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trialPhilip M Bath, Lisa J Woodhouse, Jason P Appleton, et al.
Circulation. Cardiovascular Interventions|June 6, 2018
Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients)Usman Baber, Shawn X Li, Rebecca Pinnelas, et al.
Journal of the American College of Cardiology|November 4, 2016
2-Year Outcomes of High Bleeding Risk Patients After Polymer-Free Drug-Coated StentsPhilippe Garot, Marie-Claude Morice, Damras Tresukosol, et al.
The New England Journal of Medicine|November 25, 2006
Bivalirudin for patients with acute coronary syndromesGregg W Stone, Brent T McLaurin, David A Cox, et al.
Annals of Internal Medicine|January 29, 2019
External Validation of the MEESSI Acute Heart Failure Risk Score: A Cohort StudyDesiree Wussler, Nikola Kozhuharov, Zaid Sabti, et al.
Circulation|September 13, 2022
Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection FractionJaved Butler, Gerasimos Filippatos, Tariq Jamal Siddiqi, et al.
The New England Journal of Medicine|October 27, 2025
Transcatheter or Surgical Aortic-Valve Replacement in Low-Risk Patients at 7 YearsMartin B Leon, Michael J Mack, Philippe Pibarot, et al.
Lancet (London, England)|September 2, 2025
β blockers after myocardial infarction with mildly reduced ejection fraction: an individual patient data meta-analysis of randomised controlled trialsXavier Rossello, Eva Irene Bossano Prescott, Anna Meta Dyrvig Kristensen, et al.
JAMA|February 15, 2007
Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trialGregg W Stone, Michel E Bertrand, Jeffrey W Moses, et al.
Lancet (London, England)|March 24, 2009
Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trialsMark A Hlatky, Derek B Boothroyd, Dena M Bravata, et al.
Pageof 35